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Abstract  
Background. Oxidative stress and inflammation may contribute to anabolic resistance in response to 
protein and exercise in older adults. We investigated whether consumption of montmorency cherry 
concentrate (MCC) increased anabolic sensitivity to protein ingestion and resistance exercise in 
healthy older men.  
Methods. Sixteen healthy older men were randomised to receive MCC (60ml.d-1) or placebo (PLA) 
for two weeks, after baseline measures in week 1. During week 3, participants consumed 10g whey 
protein.d-1 and completed three bouts of unilateral leg resistance exercise (4 x 8-10 repetitions at 80% 
1RM). Participants consumed a bolus (150mL) and weekly (50mL) doses of deuterated water. Body 
water 2H enrichment was measured in saliva and vastus lateralis biopsies were taken from the non-
exercised leg after weeks 1, 2 and 3, and the exercised leg after week 3, to measure tracer 
incorporation at rest, in response to protein and protein+exercise.  
Results. Myofibrillar protein synthesis increased in response to exercise+protein compared to rest 
(p<0.05) in both groups, but there was no added effect of supplement (MCC: 1.79±0.75 EX vs 
1.15±0.40 rest; PLA: 2.22±0.54 vs 1.21±0.18; all %.d-1). Muscle total NFĸB protein was decreased 
with exercise and protein in MCC (NFĸB: -20.7±17.5 %) but increased in PLA (NFĸB: 17.8±31.3 %, 
p=0.073).  
Conclusion. Short-term MCC ingestion does not affect the anabolic response to protein and exercise 
in healthy, relatively active, older men, despite MCC ingestion attenuating expression of proteins 
involved in the muscle inflammatory response to exercise, which may influence the chronic training 
response. 
 
Keywords: polyphenols, inflammation, deuterated water, myofibrillar, montmorency.  
3 
 
 
Introduction 
Progressive age-related loss of muscle mass (sarcopenia) commences in the 4/5th decade and 
accelerates from the 6th decade onwards with per annum losses in the order of 0.5 – 1.5% (1), and ~ 
1.5 % per annum strength losses (2). These declines lead to a loss of independence and impaired quality 
of life in otherwise healthy older individuals (2), so interventions that limit age-related loss of muscle 
mass and function are urgently required. 
 
The response of muscle protein synthesis (MPS) and breakdown (MPB) to nutritional intake and 
activity levels maintain muscle mass in healthy adults. Decreases in muscle mass occur as a 
consequence of MPB chronically exceeding MPS. Basal rates of MPS (3) and MPB (4) do not seem to 
be affected by age per se in healthy men. Small elevations in MPB after resistance exercise (RE) 
related to the activation of the ubiquitin proteasome and autophagal lysosomal systems are not 
augmented in older people (5). However it is clear that older subjects display resistance to anabolic 
signals such as provision of essential amino acids (3) and RE (6), resulting in attenuated MPS responses 
compared to their younger counterparts, which is pivotal to the progression of sarcopenia. The 
mechanisms underlying this blunted response to feeding and exercise are still unclear, but are likely 
associated with age-related declines in habitual activity (7; 8), and low level but chronic oxidative stress 
and inflammation.  
 
Oxidative stress related carbonylation of muscle proteins has been associated with the age-related 
muscle mass loss in rodents (9). Markers of oxidative damage are also elevated in muscle tissue 
biopsied from elderly men, with mitochondrial protein carbonyl adducts more abundant in muscle of 
old versus young men and associated with reduced muscle strength (10). The inflammatory pathway 
is also implicated in age-related anabolic resistance. TNFα seems to impair MPS via decreased 
phosphorylation of proteins in the mTOR signalling pathway (11), that is critical for regulation of 
mRNA translation and the MPS increases required for muscle hypertrophy (12). In elderly muscle we 
found a 4-fold elevation in NF-kB concentration, which was associated with a reduction in 
concentration and phosphorylation of key components of the muscle protein synthesis response 
(mTOR, p70s6k and eIF4BP-1) to AA provision (3). 
 
Control of this underlying inflammation would appear to be an appropriate target for therapeutic 
intervention. However, acute anabolic effects of RE seem to be, at least in part, mediated through a 
brief induction of NF-kB signalling and downstream inflammatory pathway gene expression (IL-6, 
IL-8, MCP-1) (13). Interestingly non-steroidal anti-inflammatory agents (NSAIDs) that inhibit cyclo-
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oxygenase activity (COX 1 and 2) exert opposite effects in young and elderly muscle: blocking the 
normal anabolic response to acute resistance exercise in young men (14), reducing the hypertrophy 
associated with an 8 week resistance training programme (15), in parallel with abolition of the usual 
increase in the anabolic agent prostaglandin F2a, a COX product (16). In contrast daily consumption 
of acetaminophen or ibuprofen during a 12 week resistance training programme augmented (~25-
50%) muscle hypertrophy and strength gains in elderly individuals (17). Although muscle protein 
turnover data are not available, Trappe et al (18) demonstrated that NSAID consumption in parallel 
with a resistance training programme upregulated PGF2α receptors, and reduced intramuscular PGE2 
production in the elderly. We propose therefore that this discrepancy in NSAID effects in the young 
and old, whereby anabolic sensitivity to exercise is restored in the old but not the young, by 
counteracting the low level chronic systemic inflammation present in the elderly. Certainly NSAIDs 
were not able to attenuate atrophy induced 2 weeks of immobilisation or enhance hypertrophy during 
2 weeks of retraining in healthy older adults with low plasma C reactive protein concentration (19). 
 
The known side effects associated with chronic NSAIDs supplementation, including gastrointestinal 
injury (20), would prevent the chronic application of this prophylactic approach to ameliorate 
sarcopenia. However, there is increasing interest in the application of nutritional supplements with 
known anti-inflammatory effects such as omega-3 fatty acids, which restored anabolic sensitivity to 
amino acids and hyperinsulinaemia in older individuals (21). Tart cherries are rich in polyphenols, the 
anthocyanins and proanthocyanidins in particular (22; 23). In vitro cherries are potent anti-oxidants (22; 
23) and inhibit COX1 (22; 23) and COX2 (23) activity. In mice, tart cherry juice consumption increased 
hepatic superoxide dismutase and glutathione peroxidase activity and inhibited COX2 activity (24), 
possibly mediated by activation of the nuclear erythroid 2-related factor 2 (Nrf2) pathway resulting 
in increased synthesis of endogenous antioxidants (25). A number of studies including our own have 
demonstrated that montmorency cherry juice improves functional recovery from a single bout of 
intensive resistance (26) or endurance exercise (27), with associated reductions in circulating biomarkers 
of oxidative damage (protein carbonyls) and inflammation (C reactive protein). We hypothesised that 
this cherry-induced reduction in oxidative stress and inflammation will restore anabolic sensitivity in 
older adults. Our aim was to determine whether two weeks of daily montmorency cherry concentrate 
(MCC) supplementation enhanced the anabolic response to protein supplementation and resistance 
exercise in healthy older men, measured as free-living myofibrillar protein synthesis using the 
deuterated water technique (28). 
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Methods 
Participants 
The study was approved by the local university ethics committee, and was conducted in compliance 
with the World Medical Association’s Declaration of Helsinki (2008). We screened and recruited 
sixteen healthy older men aged 60-75y, all of whom gave their written informed consent to 
participate. Exclusion criteria included allergy to local anaesthetic or iodine, reporting more than 150 
min moderate/vigorous activity per week (in addition to tasks of daily living), consumption of anti- 
inflammatory medication or nutritional supplements, neuromuscular problems or acute knee/ ankle 
injuries and pain.  
 
Experimental design 
Participants completed a three week experimental period in this double blind randomized control 
trial, which included four laboratory visits. During the first week participants were instructed to 
maintain habitual activity and diet. During week 2 and 3 participants consumed 30 mL of either 
Montmorency cherry concentrate (MCC) or cherry flavoured isoenergetic placebo (PLA) twice per 
day (morning and evening); diluted with water 5:1. Additionally participants consumed 10g of protein 
each day in week 3 and completed three unilateral resistance training sessions (Figure 1). MCC 
provided 40g CHO, 192 kcal and 540 mg anthocyanins per day (HPLC analysis, Atlas Bioscience 
Inc). PLA contained cherry flavoured cordial (Blossom Cottage, Bottle green) and sugar to match 
CHO (40g) and energy content. 
 
 
Figure 1: Experimental protocol. RET = resistance exercise training, each session consisted of four 
sets of 8-10 repetitions at 80% one repetition maximum 
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Experimental protocol  
At the first laboratory visit, participants gave baseline saliva and blood samples, after which they 
received three 50 mL doses of D2O separated by at least 30 min. Participants completed a physical 
activity questionnaire (IPAQ), and body weight and height were measured, and the single leg knee 
extension one repetition maximum (1RM) was estimated using a 10 repetition maximum (10RM) 
protocol whereby 1RM was calculated using the weight lifted/ (1.0278-0.0278* number of completed 
repetitions) (29). The exercising leg was counterbalanced for leg dominance across participants and 
supplement group. After this participants departed with instructions to provide a further saliva sample 
3 h after consuming the last D2O dose. This was stored in the fridge and returned at the next visit one 
week later. At the second visit, after collecting a saliva and blood sample, the first muscle biopsy 
(PRE-SUP) was taken from the vastus lateralis muscle of the non-exercising leg. A further 50 ml dose 
of D2O was consumed, and a saliva sample collected 3 h later. Participants were provided with 4 x 
210 mL bottles containing either an isoenergetic placebo (PLA) or CherryActive concentrate (MCC) 
and instructed to consume 30 mL every morning and evening for the following 2 weeks. One week 
later participants returned to the laboratory for saliva, blood and muscle sample from the control leg 
(SUP), and a final 50 ml dose of D2O. After this participants completed the first single leg knee 
extension exercise training session (see below), and consumed 10g whey protein (MyProtein). A 
saliva sample was collected 3 h after the final D2O dose. Participants completed two further training 
sessions each separated by 48 h. Participants consumed 10g whey protein every day between 
breakfast and lunch on non-training days and immediately post training on training days. Twenty-
four hours after the last training session, participants returned for a final laboratory visit, at which 
saliva and blood samples were collected and muscle biopsies were taken from the rested (SUP+PRO) 
and exercised (SUP+PRO+Rex) leg. 
 
Muscle, saliva and blood collection 
Muscle biopsies were obtained from the vastus lateralis under local anaesthesia (2 % lidocaine) using 
5 mm Bergstrom needles with suction, frozen in liquid nitrogen, and stored at -80 °C until later 
analysis. Supplements were consumed after biopsy collection on test visits to avoid contraindications. 
Saliva samples were collected > 30 min post food or drink ingestion at each laboratory visit and at 3 
h post ingestion of each D2O dose. Samples were centrifuged at 4000 rpm for 10 min at 4 OC and the 
supernatant stored in eppendorfs at -80 °C. Blood samples were collected via venipuncture at each 
laboratory visit and aliquots of plasma and serum were then frozen at -80 °C until later analysis for 
serum IL6 and protein carbonyls using a commercially available assay kit (IDS and Biocell 
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respectively). Plasma hsCRP concentration was measured via immunoturbidometric method using a 
Roche P800 analyser (Roche 800, Mannheim, Germany).  
 
Diet and Physical activity 
Participants completed three day weighed food diaries during weeks 2 and 3, and diaries were 
analysed using Compeat nutritional analysis software (Nutrition Systems, Banbury, UK). Physical 
activity was assessed using GeneActiv accelerometers (ActivInsights Ltd., Kimbolton, 
Cambridgeshire, United Kingdom), placed on the left wrist of participants after collection of the 
second biopsy and worn continuously for the next seven days. Triaxial acceleration was measured 
between ±8g, at 100Hz. At the end of the data collection period, data were downloaded to a personal 
computer according to manufacturer’s instructions and raw triaxial acceleration values were 
converted to resultant acceleration. Vector magnitude (VM) was taken from the three axes and then 
subtracted by the value of gravity (g) as in (x2 + y2 + z2)½ – 1 (30). Data were then averaged over 60s-
epochs and previously validated acceleration cutpoints were then applied to identify sedentary time 
and time spent performing light, moderate and vigorous physical activity over the one week period 
(30). 
 
Resistance exercise protocol  
The participants completed the single leg resistance exercise (leg press) on three occasions. On each 
occasion the participants completed a standardised warm-up which consisted of 12 repetitions at 40% 
1RM, 10 repetitions at 50% 1RM, 8 repetitions at 60% 1RM and 2 repetitions at 70% 1RM 
Participants then completed four sets of 8-10 repetitions at 80% 1RM separated by 2 min. When 
participants could not lift the weight and complete 10 repetitions the weight was subsequently 
lowered by 2.5kg for the next set, weight was never increased. 
 
Muscle Protein Synthesis  
Body water enrichment was determined through direct liquid injection of saliva samples (0.1µl 
volume) into a High Temperature Conversion Elemental Analyser (TC/EA; Thermo Finnigan, 
Thermo Scientific, Hemel Hempstead, UK) connected to an Isotope Ratio Mass Spectrometer (IRMS, 
Delta V Advantage, Thermo, UK). Myofibrillar and sarcoplasmic protein fractions were isolated from 
~30-50 mg of muscle as previously described (22). (28) Myofibrillar protein derived AA were 
derivatized as their n-methoxycarbonyl methyl esters (MCME) (28) and incorporation of deuterium 
into protein bound alanine was determined by gas chromatography-pyrolysis isotope ratio mass 
spectrometry (Delta V Advantage, Thermo Scientific, Hemel Hempstead, UK), alongside a standard 
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curve of known L-Alanine-2,3,3,3-d4 enrichment. The deuterium isotopic enrichment provided as 
δ2H was converted to atom % using the following equation: 
 
Atom%  = 100 x AR (ɗ2H x 0.001 + 1) 
                 1 + AR (ɗ2H x 0.001 + 1) 
 
Where, AR represents the absolute ratio constant for deuterium based on the VSMOW standard and 
equates to 0.00015595. This was then converted to atom % excess (APE) by correcting for baseline 
sample i.e. background enrichment.  
 
The fractional synthetic rate (FSR) of myofibrillar (MyoPS) protein synthesis was determined from 
the incorporation of deuterium labelled alanine into protein, using the enrichment of body water 
(corrected for the mean number of deuterium moieties incorporated per alanine, 3.7) as the surrogate 
precursor labelling between subsequent biopsies. In brief, the standard equation: 
𝐹𝑆𝑅 = −𝐿𝑛(1 −	+(𝐴𝑃𝐸𝑎𝑙𝑎)(𝐴𝑃𝐸𝑝) 4𝑡 6 
Where, APEala = deuterium enrichment of protein bound alanine, APEp = mean precursor 
enrichment over the time period and t is the time between biopsies. 
 
Muscle Protein and Gene Expression 
Muscle lysate was extracted by homogenizing muscle in 10ul/mg of ice-cold homogenization buffer 
[50 mM Tris·HCl (pH 7.4), 50mMNaF, 10mM β-glycerophosphate disodium salt, 1 mM EDTA, 1 
mM EGTA, and 1 mM activated Na3VO4 (all from Sigma-Aldrich)] and a complete protease inhibitor 
cocktail tablet (Roche, West Sussex, UK). Protein concentrations were determined by 
spectrophotometry (NanoDrop Lite); with samples  standardized to 1 mg ml−1 by dilution with 3× 
Laemmli loading buffer and heated at 95°C for 5 min. Sarcoplasmic protein fractions were analyzed 
as described previously(31), with four biopsies for each participant analysed on the same gel with each 
gel containing participants from both experimental groups to control for intra-assay variability.  
Briefly ~15µg/well of protein was separated on 4–20% gradient gels (BioRad Criterion; Bio-Rad 
Laboratories), using XT mops running buffer (Biorad) and transferred to PVDF membranes 
(Immobilon-P; Millipore, Bedford, MA). After blocking, membranes were incubated with 
appropriate antibodies diluted 1:200 at 4°C overnight: phospho-NFκB S536 (Cell Signaling 
Technology 93H1), total NFκB (Cell Signaling Technology), total IκκB (Cell Signaling Technology), 
TNF-α (Cell Signaling Technology), and COX-1 (Abcam). Membranes were subsequently incubated 
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with secondary antibodies and exposed with enhanced chemiluminescent substrate (Millipore) 
captured using a chemiluminescent imaging system (Chemidoc, Bio-rad), with sizes of the 
immunodetected proteins confirmed by molecular weight markers (ladder, Invitrogen). Blots were 
stripped in stripping buffer (ThermoFisher) for 5-10 minutes at room temperature. Membranes were 
then re blocked, incubated with secondary antibody and exposed as above to test for sufficient 
antibody removal, with stripping performed no more than once when required. Equal protein loading 
was verified by Coomassie staining, shown to be preferential loading control as discussed in (32). 
 
Briefly, total RNA was isolated from 5-10 mg of muscle using TRizol (LifeTechnologies, 
ThermoFisher Scientific) and resuspended in 22 µl of RNase-free water and quantified by 
spectrophotometry  (NanoDrop Lite). For RT-qPCR 500 ng of total RNA was reversed-transcribed 
with the high-capacity cDNA reverse transcription kit (Life Technologies) according to 
manufacturer’s protocol. The resulting cDNA was diluted 1:5 and 1 µl was added per well of the 384-
optical well plates (Life Technologies). Exon specific primers were mixed with SYBR Select Master 
Mix (Life Technologies) and 11 µl of master-mix added to each well, with each sample run in 
triplicate on a ViiATM 7 Real-Time PCR System (Life Technologies). To control for RNA input, 
PPIA levels were measured and target mRNA expression was quantified using the ΔΔCt method (33).  
 
Statistics 
Participant characteristics were analysed using independent samples t-test. Data were analysed by 
two way mixed model ANOVA condition (cherry, placebo) vs time (basal, SUP, SUP+PRO, 
SUP+PRO+EX) to determine whether MCC and PLA differentially affected: resting measures, 
protein response, and protein and exercise response. Post hoc analysis was completed to identify the 
specific location of differences with Bonferroni correction for multiple comparisons. Statistical 
significance was accepted at p<0.05. Analysis was performed using SPSS version 22 (IBM, Chicago, 
Illinois, USA), data are presented as mean±SD unless otherwise stated. 
Tissue was not obtained from one participant at baseline and for another participant after week 1 of 
supplementation therefore data is expressed as n= 8 in PLA and n=6 in SUP. In all other measures 
n=8 in SUP and PLA. 
 
 
 
10 
 
  
11 
 
Results 
Participant characteristics and physical activity 
All measured anthropometric characteristics, knee extensor strength, and training load did not differ 
between groups (Table 1). There was no difference between groups in either the amount of time spent 
completing moderate and vigorous physical activity or sedentary time (Table 1). Nor was there any 
significant difference in the energy or protein intake between groups in either week 2 or 3 of the 
protocol. However, protein intake was significantly higher in both groups in week 3 than 2 with the 
daily consumption of 10g whey protein (p=0.004, Table 2). 
 
Table 1. Anthropometric and training data 
 MCC PLA 
Age (y)   
Weight (kg) 83.8 ± 13.9 76.1 ± 9.3 
Height (m) 1.76 ± 0.12 1.77 ± 0.05 
BMI (kg.m-2) 26.4 ±1.7 24.4 ± 2.7 
1RM (kg) 36.1 ± 8.2 37.9 ± 10.2 
Training load during exercise week (kg) 1699 ± 379 1798 ± 478 
MVPA (min·d-1) 117 ± 55 153 ± 69 
Sedentary time (min·d-1) 429 ± 130 396 ± 208 
 
Means ± SD for participants in the cherry (MCC) and placebo (PLA).  1RM = one repetition maximum. MVPA 
= Moderate and vigorous physical activity 
 
Table 2. Nutritional analysis data. 
 
 Week 2 Week 3 
Group Energy 
Intake 
(kcal.d-1) 
Protein intake  
(g.kgBM.d -1) 
Energy 
Intake 
(kcal.d-1) 
Protein intake  
(g. kgBM.d-1)* 
MCC 1462 ± 206 0.79 ± 0.10 1560 ± 494 0.99 ± 0.25 
PLA 1967 ± 375 1.05 ± 0.32 1944 ± 359 1.22 ± 0.23 
 
Means ± SD for participants in the cherry (MCC) and placebo (PLA) groups during weeks 2 and 3 of the 
protocol, n=8 per group, * - significantly different to week 2, p<0.05 
 
Saliva enrichment  
Saliva 2H enrichment changed significantly over time (main effect of time p <0.01, Figure 2) but 
these differences were not affected by condition.   
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Figure 2: Time course of saliva enrichment (Delta Excess) throughout the experimental period. Data is shown 
pre (0, 7d) and following (14, 21d) supplementation of either montmorency cherry juice (MCC, closed circles) 
or a placebo (PLA, open circles). 
 
Myofibrillar protein synthesis 
Myofibrillar protein synthesis changed significantly across the experimental period (main effect of 
timepoint, p<0.001), with MPS significantly higher after exercise+protein compared to all other time 
points (p<0.05, Figure 3). However, in the non-exercised leg protein alone did not increase MPS, nor 
was the increase in MPS induced by exercise and protein significantly different between supplements 
(22±19 %, MCC; 39±11 %, PLA; p=0.4).  
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Figure 3: Myofibrillar protein synthesis at baseline and in response to one week of supplementation 
(SUP) either with Montmorency cherry extract (MCC; black bars) or placebo (white bars), two weeks 
of supplementation and consuming 10g protein per day for one week in the rested leg (SUP+PRO), 
and the exercised leg (SUP+PRO+EX). Data are presented as mean±SE, n=8 in PLA and n=6 in SUP.  
# time effect compared to all other timepoints 
 
Muscle Protein Expression 
All western data are presented relative to Coomassie density. Total NFĸB (Figure 4a) tended to 
increase in response to exercise and protein in the PLA condition (+18%) but to decline in the MCC 
condition (-21%) (p=0.073, main interaction effect). Phosphorylated-NFĸB (Figure 4b) increased 
significantly after protein and exercise (p=0.023, main time effect), but these changes were not 
affected by condition. Neither muscle TNFα nor COX1 protein expression changed in response to 
exercise or protein supplementation in either condition (table 3). 
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Figure 4 Expression of A – total NFĸB protein and B - pNFĸB protein in the sarcoplasmic muscle 
fraction at baseline and in response to one week of supplementation (SUP) either with Montmorency 
cherry extract (MCC; black bars) or placebo (white bars), two weeks of supplementation and consuming 
10g protein per day for one week in the rested leg (SUP+PRO), and the exercised leg 
(SUP+PRO+EX). Data are presented as mean±SE, n=8 for PLA, and n=7 for MCC except basal 
where n=6; * p<0.05 main interaction effect versus SUP. 
 
 
 
 
15 
 
Table 3: Muscle protein and gene expression and serum markers of inflammation 
Parameter  Basal SUP SUP+PRO SUP+PRO+EX 
COX 1 protein 
(AU) 
MCC 
PLA 
0.79 ± 0.21 
0.73±0.28 
1.07 ± 0.43 
0.72 ± 0.27 
1.02 ± 0.70 
0.74 ± 0.29 
0.83 ± 0.24 
0.74 ± 0.22 
TNFα protein 
(AU) 
MCC 
PLA 
0.71± 0.26 
0.80± 0.63 
0.72 ± 0.36 
0.88 ± 0.75 
0.74 ± 0.53 
0.92 ± 0.70 
0.66 ± 0.47 
0.94 ± 0.58 
COX 1 gene 
expression (AU) 
MCC 
PLA 
0.05± 0.03 
0.07± 0.05 
0.04 ± 0.02 
0.10 ± 0.08 
0.05 ± 0.04 
0.07 ± 0.02 
0.07 ± 0.04 
0.09 ± 0.07 
TNFα gene 
expression (AU) 
MCC 
PLA 
0.33± 0.35 
0.25± 0.14 
0.22 ± 0.04 
0.22 ± 0.07 
0.13 ± 0.04 
0.24 ± 0.14 
0.26 ± 0.24 
0.24 ± 0.08 
NFĸB gene 
expression (AU) 
MCC 
PLA 
1.46±1.02 
1.17 ±0.40 
1.26 ± 0.58 
1.21 ± 0.60 
0.87 ± 0.36 
0.97 ± 0.40 
1.54 ± 0.89 
1.21 ± 0.64 
IL1B gene 
expression (AU) 
MCC 
PLA 
0.27 ± 0.18 
0.22 ± 0.13 
0.20 ± 0.04 
0.16 ± 0.05 
0.13 ± 0.06 
0.20 ± 0.11 
0.21 ± 0.04 
0.20 ± 0.08 
NrF2 gene 
expression (AU) 
MCC 
PLA 
1.91 ± 1.00 
1.93 ± 0.74 
2.21 ± 1.10 
1.68 ± 0.58 
1.96 ± 0.75 
2.32 ± 1.00 
3.34 ± 2.82 
1.98 ± 0.84 
Serum IL6 
 
Plasma CRP 
 
Serum protein 
carbonyls 
MCC 
PLA 
MCC 
PLA 
MCC 
PLA 
1.58 ± 0.78 
1.29 ± 0.98 
2.24 ± 1.48 
2.34 ± 3.36 
0.04 ± 0.01 
0.04 ± 0.02 
1.84 ± 1.46 
0.92 ± 0.49 
1.64 ± 0.84 
1.41 ± 1.38 
0.04 ± 0.01 
0.04 ± 0.01 
1.61 ± 1.39 
1.03 ± 0.90 
2.12 ±2.01 
0.68 ±0.71 
0.04 ± 0.01 
0.03 ± 0.01 
Means ± SD for participants in the cherry (MCC) and placebo (PLA) groups. 
 
 
Muscle Gene Expression 
There were no effects of supplement, protein, or protein + exercise on expression of Nrf2, TNFα, 
COX1, NFĸB or IL1β genes (table 3).  
 
Plasma Analytes 
Protein carbonyls, CRP and IL6 were not different at any time point and there was no effect of 
supplement (p>0.05) (table 3).  
 
Discussion 
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Short term consumption of montmorency cherry concentrate providing ~540 mg anthocyanins.d-1 in 
healthy, relatively active, older men did not influence myofibrillar protein synthesis rates. However, 
the exercise-induced changes in NFƘB protein expression in muscle tended to be attenuated by MCC 
consumption. The effect of such inflammatory pathway changes on the adaptive response to exercise, 
require further investigation. Our data demonstrate that three resistance training sessions with 
consumption of additional protein (10g.d-1) augmented the response of myofibrillar protein synthesis 
over a one-week free-living period in healthy older men. However consumption of additional protein 
(10g.d-1) on its own was not sufficient to induce an anabolic response.  
 
In response to a bout of RE, MPS is acutely (60-90 mins) increased in healthy young and older men 
(6) and these effects may last for up to 48h after exercise, at least in young men (34). This response is 
augmented when combined with protein intake both in young (35) and older adults (6); therefore 
repeated bouts of RE with supportive nutrition should ultimately lead to muscle hypertrophy. D2O 
enables longer-term integrated measures of MPS that captures these combined responses over days 
and weeks. Using this technique we have previously shown heightened MPS in young individuals of 
~ 1.8%.d-1 over eight days of RE training (28) and this elevated MPS with RE is sustained for ~ three 
weeks. The magnitude of both acute and integrative measures of MPS decline thereafter, despite 
continued progression of exercise intensity (36). Here we show that in response to three bouts of RE 
and daily protein supplementation integrated MPS is increased to ~1.7-2%.d-1 over seven days in 
healthy older men, similar to values we have previously reported in young subjects over this time (28). 
However, there was no effect of MCC supplementation.  
 
There are limited comparative data for integrative MPS measures in older adults. Recently, MPS was 
shown to be increased over 3d with one bout of RE (3 sets to failure at 50% 1RM, ~15-24 reps) from 
1.48%.d-1 to ~1.71%.d-1. This effect was augmented to 1.87%.d-1 by the consumption of additional 
dietary leucine (5 g per meal to achieve 15g.d-1) (37). In support of this data, our participants completed 
three bouts of RE (four sets of 8-10 reps at 80 % 1RM) and consumed an additional 10g of whey 
protein (~1.6g Leu) per day over the 7d period and achieved higher rates of MPS 2.0%.d-1, suggestive 
of a sustained effect. In common with these studies our data indicate that an acute MPS response (< 
1week) to RE occurs in older adults. However, the role this increase has on muscle homeostasis and 
contributions to muscle hypertrophy are unclear. For instance if these rates of MPS were maintained 
in the absence of changes in MPB, considerable hypertrophy would be expected, when in fact RE 
training-induced hypertrophy is often attenuated in older versus young participants (38). In addition, 
we have recently shown in young and older individuals undertaking the same RE training (at least in 
terms of relative intensity) that old subjects showed blunted MPS over three weeks and this is 
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reflected with impaired muscle hypertrophy (39). The initial higher rates of MPS, observed over 2d 
(40), 3d (37) and 7d in this study may simply be the result of substantial repair processes that occur in 
response to bouts of RE to which participants were relatively unaccustomed. Ultimately the 
magnitude of response may subside as responses become more ‘hypertrophy specific’ with continued 
RE training (41). In support of this, well-trained master athletes, displayed MPS rates of ~ 1.4%.d-1 
over 3 d in response to intense endurance exercise, compared with 1.7%.d-1 in young triathletes (42).  
 
We chose a lower dose of protein intentionally, to elicit a sub-maximal anabolic response such that 
there was still capacity to reveal any additional anabolic effects of MCC. Our participants were 
relatively active completing 135 (± 60) min of objectively measured moderate-to-vigorous activity 
per day (equivalent to 14.7 % of waking hours) in this study - close to the FAO/WHO/UNU 
recommendation of 15% of waking hours in MVPA (43). It is important to note that the MPS measures 
incorporated the integrated effects of habitual activity and dietary behaviour throughout the week. A 
small effect of MCC on MPS could therefore be masked by small changes in either physical activity 
levels and/or protein intake, especially in view of the relatively small sample size for MPS due to the 
loss of muscle tissue. Habitual protein intake was also sufficiently low (<1 g.kg-1 BM.d-1) to 
potentially hamper optimal MPS response. The effect that habitual protein intake and activity levels, 
individually or in combination, have on integrated measures of MPS is unknown and requires further 
study.  
 
We hypothesised that MCC would enhance anabolic responses in older men by attenuating oxidative 
damage and inflammation. However, the healthy older male participants in this study did not exhibit 
elevated systemic markers of inflammation (CRP and IL6); nor was there any elevation in protein 
carbonyls (a marker of oxidative modification of protein). These blood data suggest that the study 
population were not experiencing the systemic oxidative stress and inflammation suggested to 
contribute to age-related anabolic resistance. It is perhaps unsurprising, therefore, that in these 
circumstances no effects of MCC on MPS response to exercise and protein were observed, and future 
studies should focus upon frail elderly participants exhibiting anabolic resistance. However, 
consistent with our hypothesis there was evidence of a reduced inflammatory response within the 
exercised muscle after MCC consumption, with decreases in NFĸB protein expression after exercise 
in the montmorency cherry condition whereas expression of these proteins was increased in the 
placebo condition. The long term consequences of such changes on the responsiveness of young and 
older muscle to chronic training may warrant investigation, since non-steroidal anti-inflammatory 
medication appears to enhance resistance training induced muscle mass and strength gains in older 
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participants (17) whilst suppressing the acute MPS response to resistance exercise in healthy active 
young men (14).  
 
Perhaps unsurprisingly, there were no changes in muscle gene expression in response to supplement, 
protein and/or exercise, given that Murton et al (44) found that muscle gene expression was elevated 
24h after an initial bout of damaging exercise in healthy young men, but when a second identical 
exercise bout was performed 48h later, these changes were significantly attenuated.  
 
In conclusion, short-term ingestion of Montmorency cherry concentrate does not significantly affect 
the anabolic response to protein and exercise in healthy, relatively active, older men and who are not 
showing signs of inflammation. However, montmorency cherry concentrate ingestion appears to 
reduce exercise-induced increases in muscle proteins involved in the inflammatory response.  
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